logo
  

Build-A-Bear Workshop Appoints Voin Todorovic As CFO

Build-A-Bear Workshop, Inc. (BBW) said Monday that it has appointed Voin Todorovic as its new Chief Financial Officer, effective September 15.

Todorovic was most recently employed at Wolverine World Wide, Inc. as the head of finance and operations for its Lifestyle Group which includes a portfolio of iconic brands such as Sperry Top-Sider, Hush Puppies, Keds, and Stride Rite. Prior to his tenure at Wolverine World Wide he held positions of increasing responsibility at Payless Shoe Source and Collective Brands.

Todorovic will assume the Chief Financial Officer responsibilities from Tina Klocke, who had been serving as both Build-A-Bear's Chief Financial Officer and Chief Operating Officer.

In conjunction, Build-A-Bear announced Klocke's intent to leave the company to pursue her interests in the not-for-profit business sector. Klocke will remain with the company through the first quarter of 2015 and will retain her position as Chief Operating Officer during that time.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT